News - Sunshine Labs

09/12/2025

Sunshine Labs pioneers Global Health Solutions by producing and delivering cutting-edge pharmaceuticals and medical technologies. We often direct enquiring healthcare practitioners and patients to Canada’s Special Access Program, which facilitates access to novel treatments for patients when conventional treatments have failed. What it is Health Canada’s Special Access Program (SAP) allows healthcare practitioners to request … Continued

News

09/12/2025

What is Our Precursors License?

Oryx Biomed Ltd., a wholly owned subsidiary of Sunshine Earth Labs Ltd., was granted a Precursors License in 2024. This means we are licensed by Health Canada for the import, export, production, packaging, sale and provision of precursor chemicals. What are Precursor Chemicals? Precursor chemicals are used in the production of controlled substances. They are … Continued

News

07/08/2025

DMT Licensing for Clinical Trials

One of our major 2025 Q3 milestones is the addition of Dimethyltryptamine (DMT) to our Health Canada Dealer’s License. DMT is a naturally occurring psychedelic compound that has gained significant attention in recent years for its potential therapeutic applications. Once known primarily for its role in traditional Amazonian medicine and its powerful hallucinogenic effects, DMT … Continued

Press

06/30/2025

Sunshine Secures a Global Partnership

Expanding Access to Life-Saving Harm Reduction Solutions June 25, 2025 Sunshine Labs is proud to announce a strategic global partnership with Speranza Therapeutics, a leader in medical device innovation and addiction medicine. This collaboration marks a major milestone in our mission to expand access to clinically effective harm reduction tools, pharmaceuticals, and medical devices across North … Continued

News

04/15/2025

Global Distribution for Detox Device

April 15, 2025 — Sunshine Labs, a leading innovator in medical technologies for Substance Use Disorder (SUD), is pleased to announce an exclusive global distribution agreement (excluding the United States) with Sperenza Therapeutics for its flagship device, S.T. Genesis™, with its wholly owned subsidiary, Waxed International. This agreement with Speranza Therapeutics grants Waxed International exclusive … Continued

News

05/07/2025

Transforming the Drug Crisis Response

Current Research on Evidence-Based Solutions As Canada and the rest of the world continue to grapple with a massive public health crisis driven by toxic, unregulated drugs, a growing body of new evidence is reshaping the response. Prescribed alternatives-commonly known as “safer supply”– are an effective, evidence-based strategy to reduce overdose deaths and improve the … Continued

News

03/11/2025

Announcing Our First Import License

Advancing Pharmaceutical Innovation with Compliance and Safety We are thrilled to announce a major milestone in our journey: the approval of our first import license for a highly specialized raw material. This marks a significant step forward in our mission to support the pharmaceutical industry with safe, compliant, and high-quality products. About The Product The … Continued

Press

01/22/2025

A Potential New Approach to Treating Addiction

GLP-1 (Glucagon-like peptide-1 receptor agonists), originally developed for type 2 diabetes and obesity, are now being explored for their potential to treat substance use disorders (SUD). Early research suggests these medications could help curb addictive behaviors, opening much needed novel treatment approaches for addiction. What is GLP-1? GLP-1 is a hormone that helps regulate blood … Continued

Company

03/06/2024

Diacetylmorphine for Addiction Treatment

The Role of Diacetylmorphine in the Safer Supply Response to the Toxic Drug Crisis The ongoing toxic drug crisis has claimed thousands of lives due to an unpredictable illegal drug supply contaminated with highly potent synthetic opioids like fentanyl. One approach that shows promise in reducing overdoses and other harms is providing a safer supply … Continued

News

02/07/2024

MDMA Therapy, FDA Approval, and Our License

Sunshine Labs holds one of the few legal licenses to produce, sell and transport MDMA through Health Canada. We have established global partnerships and supply agreements with others in this space. Sale is allowed to licensed dealers, pharmacists, practitioners, hospital employees or the Ministry. Sassafras: the Root of MDMA Sassafras, a plant native to Eastern … Continued